New Zealand markets closed

NRx Pharmaceuticals, Inc. (NRXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.5400+0.4000 (+12.74%)
At close: 04:00PM EDT
3.8000 +0.26 (+7.34%)
After hours: 07:56PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
18,984
13,371
17,027
20,257
10,625
Selling general and administrative
68,438
14,216
27,308
74,944
11,436
Total operating expenses
87,422
27,837
44,335
115,796
51,387
Operating income or loss
-87,422
-27,837
-44,335
-115,796
-51,387
Interest expense
5
120
0
18
56
Total other income/expenses net
27,388
-2,687
4,332
22,751
-334
Income before tax
-59,920
-30,150
-39,754
-93,063
-51,777
Income tax expense
-
-
0
0
0
Income from continuing operations
-59,920
-30,150
-39,754
-93,063
-51,777
Net income
-59,920
-30,150
-39,754
-93,063
-51,777
Net income available to common shareholders
-59,920
-30,159
-39,754
-348,885
-51,777
Basic EPS
-0.50
-
-6.00
-74.40
-15.10
Diluted EPS
-0.50
-
-6.00
-74.40
-15.10
Basic average shares
72,203
-
6,577
4,692
3,427
Diluted average shares
72,203
-
6,577
4,692
3,427